# ERIS — Eris Lifesciences Limited

> Eris Lifesciences Limited (ERIS) on the NSE: 2,264 sessions of split-adjusted history from 2017.

Canonical: https://patternsradar.com/s/ERIS

## Latest session

- Close: 1,328.2 INR (0.17% on the day), 2026-08-21
- Delivery: 52.93% of volume taken to demat (20-day average 60.78%)
- Volume: 57.0K shares, turnover ₹7.6Cr
- Relative volume: 0.54× of its own 20-day average

## Technicals

- RSI(14): 37.07
- ATR(14): 34.97
- SMA 50: 1,410.11, SMA 200: 1,431.07
- 52-week range: 1,200 – 1,820 (-27.02% from the high)

## Performance

- 1 week -2.23%, 1 month -4.83%, 3 months -1.16%
- 6 months -2.65%, 1 year -20.7%

## Fundamentals

- Market cap: 18,406.6 crore
- P/E (TTM): 27.65 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 48.04 INR, split-adjusted to match the price series
- Revenue growth: 12.97% YoY, 15.42% QoQ
- Profit growth: 14.56% YoY, -48.65% QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 2y | 19.48% | 30.18% |
| 3y | 22.59% | 21.11% |
| 5y | 20.56% | 12.3% |
| 6y | 19.79% | 14.11% |
| 7y | 18.14% | 11.87% |

## Quarterly results

Last 8 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2024-09-30 | 739 | 616.6 | 129.1 | 96.4 | 6.73 | 13.04% |
| 2024-12-31 | 727.5 | 615.5 | 116.2 | 86.9 | 6.15 | 11.95% |
| 2025-03-31 | 705.3 | 584.4 | 128.8 | 102.4 | 6.9 | 14.51% |
| 2025-06-30 | 773 | 615.5 | 160.2 | 125.1 | 8.66 | 16.18% |
| 2025-09-30 | 792.4 | 622.8 | 172.4 | 134.5 | 8.82 | 16.97% |
| 2025-12-31 | 807.5 | 645 | 145.2 | 108.8 | 7.32 | 13.48% |
| 2026-03-31 | 756.6 | 598.2 | 160.6 | 279.1 | 20.6 | 36.89% |
| 2026-06-30 | 873.3 | 695.8 | 179.9 | 143.3 | 10.28 | 16.41% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 54.14%
- Public: 45.86%

Institutional and pledge percentages come from a filing stage whose backfill has reached about 1% of instruments, so they are absent here rather than zero.

## Recent filings

- 2026-07-29: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_179700_29072026144904_iXBRL_WEB.html
- 2026-07-18: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1696259_18072026055934_WEB.xml
- 2026-05-29: dividend
- 2026-05-20: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_159390_20052026193151_iXBRL_WEB.html
- 2026-04-15: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1651336_15042026035241_WEB.xml
- 2026-02-13: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_142896_13022026161646_iXBRL_WEB.html
- 2026-01-15: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1601453_15012026022905_WEB.xml
- 2025-11-12: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_126682_12112025183455_iXBRL_WEB.html

Dated by the day the company broadcast the filing. 94 events are indexed for this instrument.

## About the instrument

- Listed: 2017-06-29 — latest session 2026-08-21 (2,264 sessions)
- ISIN: INE406M01024
- Series: EQ
- Liquidity rank: #889 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/ERIS.